SYNGAP1 and asthma: Respiratory co-morbidities were more common, although not significantly, in the ID-comparison group (n = 12; 8 = recurrent chest infections, 4 = asthma) compared to SYNGAP1-ID (n = 1; recurrent chest infection, p = 0.06).